These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
617 related articles for article (PubMed ID: 18855662)
21. Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease. Liu F; Liang Z; Gong CX Panminerva Med; 2006 Jun; 48(2):97-108. PubMed ID: 16953147 [TBL] [Abstract][Full Text] [Related]
22. Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation. Gong CX; Liu F; Grundke-Iqbal I; Iqbal K J Alzheimers Dis; 2006 Mar; 9(1):1-12. PubMed ID: 16627930 [TBL] [Abstract][Full Text] [Related]
23. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β. Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563 [TBL] [Abstract][Full Text] [Related]
24. Methylglyoxal induces tau hyperphosphorylation via promoting AGEs formation. Li XH; Xie JZ; Jiang X; Lv BL; Cheng XS; Du LL; Zhang JY; Wang JZ; Zhou XW Neuromolecular Med; 2012 Dec; 14(4):338-48. PubMed ID: 22798221 [TBL] [Abstract][Full Text] [Related]
25. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Sengupta A; Wu Q; Grundke-Iqbal I; Iqbal K; Singh TJ Mol Cell Biochem; 1997 Feb; 167(1-2):99-105. PubMed ID: 9059986 [TBL] [Abstract][Full Text] [Related]
26. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677 [TBL] [Abstract][Full Text] [Related]
27. Regulation of phosphorylation of tau by protein kinases in rat brain. Sengupta A; Grundke-Iqbal I; Iqbal K Neurochem Res; 2006 Dec; 31(12):1473-80. PubMed ID: 17120162 [TBL] [Abstract][Full Text] [Related]
28. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Alonso AD; Grundke-Iqbal I; Barra HS; Iqbal K Proc Natl Acad Sci U S A; 1997 Jan; 94(1):298-303. PubMed ID: 8990203 [TBL] [Abstract][Full Text] [Related]
29. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders. Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722 [TBL] [Abstract][Full Text] [Related]
30. Developing pharmacological therapies for Alzheimer disease. Iqbal K; Grundke-Iqbal I Cell Mol Life Sci; 2007 Sep; 64(17):2234-44. PubMed ID: 17604997 [TBL] [Abstract][Full Text] [Related]
31. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. Wang JZ; Wu Q; Smith A; Grundke-Iqbal I; Iqbal K FEBS Lett; 1998 Sep; 436(1):28-34. PubMed ID: 9771888 [TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. Utton MA; Vandecandelaere A; Wagner U; Reynolds CH; Gibb GM; Miller CC; Bayley PM; Anderton BH Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):741-7. PubMed ID: 9169608 [TBL] [Abstract][Full Text] [Related]
33. Post-translational modifications of tau protein in Alzheimer's disease. Gong CX; Liu F; Grundke-Iqbal I; Iqbal K J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432 [TBL] [Abstract][Full Text] [Related]
34. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation. Annamalai B; Won JS; Choi S; Singh I; Singh AK Biochem Biophys Res Commun; 2015 Feb; 458(1):214-9. PubMed ID: 25640839 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease. Wang G; Huang Y; Wang LL; Zhang YF; Xu J; Zhou Y; Lourenco GF; Zhang B; Wang Y; Ren RJ; Halliday GM; Chen SD Sci Rep; 2016 May; 6():26697. PubMed ID: 27221467 [TBL] [Abstract][Full Text] [Related]
36. [Research progress of abnormal phosphorylation of microtubule-associated tau protein and of the targeted inhibition of the phosphorylation]. Zhou F; Chen S; Sun X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):788-92. PubMed ID: 23016437 [TBL] [Abstract][Full Text] [Related]
37. Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration. Wang JZ; Wang ZH Exp Gerontol; 2015 Aug; 68():82-6. PubMed ID: 25777063 [TBL] [Abstract][Full Text] [Related]
38. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. Pei JJ; Tanaka T; Tung YC; Braak E; Iqbal K; Grundke-Iqbal I J Neuropathol Exp Neurol; 1997 Jan; 56(1):70-8. PubMed ID: 8990130 [TBL] [Abstract][Full Text] [Related]
39. Neuroglobin attenuates Alzheimer-like tau hyperphosphorylation by activating Akt signaling. Chen LM; Xiong YS; Kong FL; Qu M; Wang Q; Chen XQ; Wang JZ; Zhu LQ J Neurochem; 2012 Jan; 120(1):157-64. PubMed ID: 21496024 [TBL] [Abstract][Full Text] [Related]
40. Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk. Mateo I; Vázquez-Higuera JL; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; García-Gorostiaga I; Berciano J; Combarros O Acta Neurol Scand; 2009 Aug; 120(2):130-3. PubMed ID: 19154537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]